The Institute of Medical Biology (IMB) focusses its research portfolio on the critical and challenging interface between basic science and medicine. Our goal is to understand mechanisms underlying human disease, so that we may discover new and effective approaches to combating illness and promoting wellbeing.
Research activities in IMB today range across stem cells, regenerative medicine and genetic diseases. By studying how molecular changes lead to increasing cell specialization and complexity in the context of human tissues and diseases, new knowledge gained will lead us to novel therapeutic strategies for improved quality of life.
IMB’s research will help to build the bridges between basic science and clinical medicine that are so necessary to nurture an innovative and productive biomedical industry here in Singapore. In 2018, IMB’s expertise in Skin Biology research led to the formation of the Skin Research Institute of Singapore (SRIS), a tripartite initiative with Nanyang Technological University and the National Health Group.
Scientists and clinicians in the IMB team and beyond work closely together to support, inform and refine each other’s strengths and specializations. This increases the efficiency of translating new scientific knowledge into medically useful processes, to benefit people faster.
From Singapore and around the world, our scientists are bringing together their pioneering spirit and creative research talent to form a research institute of international excellence. The interface between science and medicine is a challenging and exciting place to be working. Nothing can be as rewarding as discovering the cause of a human disease or working out a new therapy to alleviate suffering. At the Institute of Medical Biology, we are proud and excited to be part of it.